38 related articles for article (PubMed ID: 3166241)
1. Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins.
Di Micco B; Di Micco P; Lepretti M; Stiuso P; Donnarumma G; Iovene MR; Capasso R; Tufano MA
Int J Exp Pathol; 2005 Aug; 86(4):241-5. PubMed ID: 16045546
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
Hisada Y; Kawano T; Archibald SJ; Welch JS; Reeves BN; Mackman N
Blood Adv; 2023 Sep; 7(18):5458-5469. PubMed ID: 37450381
[TBL] [Abstract][Full Text] [Related]
3. The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management.
Hermsen J; Hambley B
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444587
[TBL] [Abstract][Full Text] [Related]
4. Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care?
Hambley BC; Tomuleasa C; Ghiaur G
Front Med (Lausanne); 2021; 8():722614. PubMed ID: 34485349
[TBL] [Abstract][Full Text] [Related]
5. Effects of Preoperative Glycyrrhizin Infusion for the Prevention of Venous Thrombosis on the Tissue Expression of Antithrombin in a Rat Model.
Nakata N; Kira Y
Ann Vasc Dis; 2016; 9(2):95-101. PubMed ID: 27375802
[TBL] [Abstract][Full Text] [Related]
6. Acute promyelocytic leukaemia in the all trans retinoic acid era.
DeLoughery TG; Goodnight SH
Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
[TBL] [Abstract][Full Text] [Related]
7. Elevated thrombin-antithrombin III complex concentrations in patients with gynaecological malignancy.
Tatra G; Reinthaller A
Klin Wochenschr; 1991 Feb; 69(3):124-7. PubMed ID: 2013973
[TBL] [Abstract][Full Text] [Related]
8. Enhanced thrombin generation in patients receiving intensive care.
Balakrishnan G; Brownlie J; Webber R; Gibson B
Arch Dis Child; 1991 Dec; 66(12):1413-5. PubMed ID: 1776888
[TBL] [Abstract][Full Text] [Related]
9. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
Sakata T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
[No Abstract] [Full Text] [Related]
10. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
11. Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia.
Asakura H; Saito M; Ito K; Jokaji Y; Uotani C; Kumabashiri I; Matsuda T
Thromb Res; 1988 Jun; 50(6):895-9. PubMed ID: 3166241
[No Abstract] [Full Text] [Related]
12. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Castaman G; Ruggeri M; Rodeghiero F
Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
[No Abstract] [Full Text] [Related]
13. [Prevention and early diagnosis of disseminated intravascular coagulation].
Matsuda T
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1375-82. PubMed ID: 8245630
[No Abstract] [Full Text] [Related]
14. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
[TBL] [Abstract][Full Text] [Related]
15. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
